Innovative mRNA-based therapeutics and vaccines offer hope in the fight against cancer, genetic disorders and infections. As part of the RNAuto project, seven Fraunhofer Institutes developed an automated, digitally controlled production system that operates quickly, flexibly, and cost-effectively.